Tag: ceo

Schlieren / Zurich, Switzerland, 25 July, 2025 – Memo Therapeutics AG ("MTx”), a late-stage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer, today announced results from its Phase II clinical trial evaluating potravitug, a highly potent human BK polyomavirus (“BKPyV”)-neutralizing monoclonal antibody, for the treatment of BKPyV infection in kidney transplant recipients (“KTR”).

Communiqué de presse
Embargo jusqu'au 25 juillet 2025 à 6h50
 Information réglementée – informations confidentielles

Press release
Embargo until 25 July 2025 at 6:50 am
 Regulated information – Inside information

Persbericht
Embargo tot 25 juli 2025 om 6.50 u.
 Gereglementeerde informatie – Voorwetenschap

Vancouver, BC, July 24, 2025 (GLOBE NEWSWIRE) -- Pinnacle Food Group Limited (NASDAQ: PFAI) (“PFAI” or “the Company”), a leading innovator in the smart farming industry, is pleased to announce the appointment of Dunruo Andrew Zhu as President of Asia Pacific, effective immediately. With over 30 years of experience in commercial real estate and a proven track record of leadership, Mr. Zhu will spearhead the Company’s expansion strategy across the Asia Pacific region.

JEFFERSONVILLE, Ind., July 24, 2025 (GLOBE NEWSWIRE) -- First Savings Financial Group, Inc. (NASDAQ: FSFG - news) (the "Company"), the holding company for First Savings Bank (the "Bank"), today reported net income of $6.2 million, or $0.88 per diluted share, for the quarter ended June 30, 2025, compared to net income of $4.1 million, or $0.60 per diluted share, for the quarter ended June 30, 2024. Excluding nonrecurring items, the Company reported net income of $5.7 million (non-GAAP measure)⁽¹⁾ and net income per diluted share of $0.81 (non-GAAP measure)⁽¹⁾ for the quarter ended June 30, 2025 compared to $3.5 million, or $0.52 per diluted share for the quarter ended June 30, 2024.

Not for dissemination in the United States of America